Avenue Therapeutics, INC. (ATXI) SEC Filings — 2025

Filings

• Avenue Therapeutics Files 8-K on Shareholder Votes — 8-K · Dec 31, 2025
• ATXI Sets Virtual Annual Meeting to Elect Directors, Ratify Auditor — DEF 14A · Dec 5, 2025
• Avenue Therapeutics, INC. 8-K Filing — 8-K · Nov 18, 2025
• ATXI Narrows Losses Amid Nasdaq Delisting, AnnJi Deal Termination — 10-Q · Nov 13, 2025
• Avenue Therapeutics, INC. 8-K Filing — 8-K · Nov 12, 2025
• Avenue Therapeutics Swings to Profit on AnnJi Deal, Faces Going Concern Doubts — 10-Q · Aug 14, 2025
• Avenue Therapeutics Files Q1 2025 10-Q with Minimal Financial Activity — 10-Q · May 15, 2025
• Avenue Therapeutics Files 8-K on Agreements and Acquisitions — 8-K · Apr 30, 2025
• Avenue Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025
• Avenue Therapeutics Faces Delisting Notice — 8-K · Mar 17, 2025
• Avenue Therapeutics Files 8-K — 8-K · Mar 7, 2025